Kodiak Sciences Inc Phase 2b/3 Study in wet AMD Top-Line Results Transcript
Good afternoon, and welcome to the Kodiak Sciences Phase IIb/III study in wet AMD top line results call. My name is Marion, and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions) Today's conference is being recorded.
At this time, I would like to turn the conference over to John Borgeson, CFO of Kodiak. Please go ahead.
Thank you for joining Kodiak Sciences' conference call. I'm John Borgeson, Kodiak's Chief Financial Officer. Joining me today are Victor Perlroth, Chairman and CEO; and Jason Ehrlich, Chief Medical Officer and Chief Development Officer. After our prepared remarks, we will open the call for Q&A.
The webcast portion of this call contains a slide presentation that we will refer to during the call. Those following along on the phone who wish to access the slide portion of this presentation may do so on the Investor Relations section of our website. An archive of this webcast will be available on our website.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
